1
|
De Marco I. Coprecipitation of Class II NSAIDs with Polymers for Oral Delivery. Polymers (Basel) 2023; 15:polym15040954. [PMID: 36850237 PMCID: PMC9959069 DOI: 10.3390/polym15040954] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2023] [Revised: 02/01/2023] [Accepted: 02/14/2023] [Indexed: 02/17/2023] Open
Abstract
Non-steroidal anti-inflammatory drugs (NSAIDs) are frequently administered orally with modified-release formulations. The attainment of modified-release drugs is commonly achieved through the coprecipitation of the active principle with a biodegradable polymeric carrier in the form of micro or nanoparticles. In this review, some coprecipitation studies of three highly prescribed NSAIDs (in particular, ibuprofen, ketoprofen, and diclofenac sodium) have been analyzed. The techniques employed to micronize the powder, the polymers used, and the main results have been classified according to the type of release required in different categories, such as delayed, immediate, prolonged, sustained, and targeted release formulations. Indeed, depending on the pathology to be treated, it is possible to achieve specific therapeutic objectives, ensuring that the drug is released at a higher or lower dissolution rate (if compared to conventional drugs) and/or at a different time and/or in a specific site of action.
Collapse
Affiliation(s)
- Iolanda De Marco
- Department of Industrial Engineering, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Italy;
- Research Centre for Biomaterials BIONAM, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Italy
| |
Collapse
|
2
|
Ossowicz-Rupniewska P, Klebeko J, Świątek E, Szachnowska J, Janus E, Rangelov M, Todorova N, Taneva SG, Krachmarova E, Guncheva M. Binding behavior of ibuprofen-based ionic liquids with bovine serum albumin: Thermodynamic and molecular modeling studies. J Mol Liq 2022. [DOI: 10.1016/j.molliq.2022.119367] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
3
|
Ibuprofen molecular aggregation by direct back-face transmission steady-state fluorescence. Photochem Photobiol Sci 2022; 21:1637-1645. [PMID: 35665917 PMCID: PMC9166242 DOI: 10.1007/s43630-022-00247-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2022] [Accepted: 05/12/2022] [Indexed: 11/10/2022]
Abstract
Direct back-face transmission steady-state fluorescence was successfully applied to the study of aggregation of ibuprofen and ibuprofenate anion in solution taking advantage of its own fluorescence. The analysis of the experimental data involves the use of the differential reabsorption model to account for re-absorption phenomenon and the closed association model to describe aggregation. The fluorescence quantum yield of ibuprofenate increases when it aggregates in the presence of sodium, but it markedly decreases when 1-butyl-3-methylimidazolium is used as counterion. The proposed methodology allows the accurate determination of the critical aggregation concentrations and the mean aggregation numbers. Results were supported by complementary techniques such as time-resolved fluorescence, 1H-NMR and small-angle neutron and X-ray scattering. The developed technique constitutes a promising strategy to characterize the aggregation of poorly fluorescent surfactants that aggregates at high concentrations and hence at high absorbance values, conditions in which the most common right-angle configuration for fluorescence acquisition is troublesome due to re-absorption.
Collapse
|
4
|
Díaz Compañy A, Simonetti S. DFT study of the chemical reaction and physical properties of ibuprofen sodium. Tetrahedron 2022. [DOI: 10.1016/j.tet.2022.132899] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
5
|
Frigini EN, Porasso RD. Effect of Ionic Strength on Ibuprofenate Adsorption on a Lipid Bilayer of Dipalmitoylphosphatidylcholine from Molecular Dynamics Simulations. J Phys Chem B 2022; 126:1941-1950. [PMID: 35226503 DOI: 10.1021/acs.jpcb.1c09301] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
In this work, the free energy change in the process of transferring ibuprofenate from the bulk solution to the center of a model of the dipalmitoylphosphatidylcholine bilayer at different NaCl concentrations was calculated. Two minima were found in the free energy profile: a local minimum, located in the vicinity of the membrane, and the global free energy minimum, found near the headgroup region. The downward shift of free energy minima with increasing NaCl concentration is consistent with the results of previous works. Conversely, the upward shift of the free energy maximum with increasing ionic strength is due to the competition of sodium ions and lipids molecules to coordinate with ibuprofenate and neutralize its charge. In addition, normal molecular dynamics simulations were performed to study the effects of the ibuprofenate on the lipid bilayer and in the presence of a high ibuprofenate concentration. The effect of ionic strength on the properties of the lipid bilayer and on lipid-drug interactions was analyzed. The area per lipid shrinking with increasing ionic strength, volume of lipids, and thickness of the bilayer is consistent with the experimental results. At a very high ibuprofenate concentration, the lipid bilayer dehydrates, and it consequently transforms into the gel phase, thus blocking the permeation.
Collapse
Affiliation(s)
- Ezequiel N Frigini
- Instituto de Matemáticas Aplicada San Luis, CONICET, Facultad de Química, Bioquímica y Farmacia, Universidad Nacional de San Luis, Avenida Ejército de los Andes 950, 5700 San Luis, Argentina
| | - Rodolfo D Porasso
- Instituto de Matemáticas Aplicada San Luis, CONICET, Facultad de Ciencias Físico Matemáticas y Naturales, Universidad Nacional de San Luis, Avenida Ejército de los Andes 950, 5700 San Luis, Argentina
| |
Collapse
|
6
|
Ivshina IB, Tyumina EA, Bazhutin GA, Vikhareva EV. Response of Rhodococcus cerastii IEGM 1278 to toxic effects of ibuprofen. PLoS One 2021; 16:e0260032. [PMID: 34793540 PMCID: PMC8601567 DOI: 10.1371/journal.pone.0260032] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2021] [Accepted: 10/29/2021] [Indexed: 11/23/2022] Open
Abstract
The article expands our knowledge on the variety of biodegraders of ibuprofen, one of the most frequently detected non-steroidal anti-inflammatory drugs in the environment. We studied the dynamics of ibuprofen decomposition and its relationship with the physiological status of bacteria and with additional carbon and energy sources. The involvement of cytoplasmic enzymes in ibuprofen biodegradation was confirmed. Within the tested actinobacteria, Rhodococcus cerastii IEGM 1278 was capable of complete oxidation of 100 μg/L and 100 mg/L of ibuprofen in 30 h and 144 h, respectively, in the presence of an alternative carbon source (n-hexadecane). Besides, the presence of ibuprofen induced a transition of rhodococci from single- to multicellular lifeforms, a shift to more negative zeta potential values, and a decrease in the membrane permeability. The initial steps of ibuprofen biotransformation by R. cerastii IEGM 1278 involved the formation of hydroxylated and decarboxylated derivatives with higher phytotoxicity than the parent compound (ibuprofen). The data obtained indicate potential threats of this pharmaceutical pollutant and its metabolites to biota and natural ecosystems.
Collapse
Affiliation(s)
- Irina B. Ivshina
- Perm Federal Research Center of the Ural Branch of the Russian Academy of Sciences, Perm, Russia
- * E-mail:
| | - Elena A. Tyumina
- Perm Federal Research Center of the Ural Branch of the Russian Academy of Sciences, Perm, Russia
| | - Grigory A. Bazhutin
- Perm Federal Research Center of the Ural Branch of the Russian Academy of Sciences, Perm, Russia
| | - Elena V. Vikhareva
- Perm Federal Research Center of the Ural Branch of the Russian Academy of Sciences, Perm, Russia
| |
Collapse
|
7
|
Salva O, Doreski PA, Giler CS, Quinodoz DC, Guzmán LG, Muñoz SE, Carrillo MN, Porta DJ, Ambasch G, Coscia E, Diaz JLT, Bueno GD, Fandi JO, Maldonado MA, Peña Chiappero LE, Fournier F, Pérez HA, Quiroga MA, Sala Mercado JA, Martínez Picco C, Beltrán MA, Argañarás LA, Ríos NM, Kalayan GI, Beltramo DM, García NH. Reversal of SARS-CoV2-Induced Hypoxia by Nebulized Sodium Ibuprofenate in a Compassionate Use Program. Infect Dis Ther 2021; 10:2511-2524. [PMID: 34460083 PMCID: PMC8404026 DOI: 10.1007/s40121-021-00527-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2021] [Accepted: 08/12/2021] [Indexed: 12/15/2022] Open
Abstract
INTRODUCTION Sodium ibuprofenate in hypertonic saline (NaIHS) administered directly to the lungs by nebulization and inhalation has antibacterial and anti-inflammatory effects, with the potential to deliver these benefits to hypoxic patients. We describe a compassionate use program that offered this therapy to hospitalized COVID-19 patients. METHODS NaIHS (50 mg ibuprofen, tid) was provided in addition to standard of care (SOC) to hospitalized COVID-19 patients until oxygen saturation levels of > 94% were achieved on ambient air. Patients wore a containment hood to diminish aerosolization. Outcome data from participating patients treated at multiple hospitals in Argentina between April 4 and October 31, 2020, are summarized. Results were compared with a retrospective contemporaneous control (CC) group of hospitalized COVID-19 patients with SOC alone during the same time frame from a subset of participating hospitals from Córdoba and Buenos Aires. RESULTS The evolution of 383 patients treated with SOC + NaIHS [56 on mechanical ventilation (MV) at baseline] and 195 CC (21 on MV at baseline) are summarized. At baseline, NaIHS-treated patients had basal oxygen saturation of 90.7 ± 0.2% (74.3% were on supplemental oxygen at baseline) and a basal respiratory rate of 22.7 ± 0.3 breath/min. In the CC group, basal oxygen saturation was 92.6 ± 0.4% (52.1% were on oxygen supplementation at baseline) and respiratory rate was 19.3 ± 0.3 breath/min. Despite greater pulmonary compromise at baseline in the NaIHS-treated group, the length of treatment (LOT) was 9.1 ± 0.2 gs with an average length of stay (ALOS) of 11.5 ± 0.3 days, in comparison with an ALOS of 13.3 ± 0.9 days in the CC group. In patients on MV who received NaIHS, the ALOS was lower than in the CC group. In both NaIHS-treated groups, a rapid reversal of deterioration in oxygenation and NEWS2 scores was observed acutely after initiation of NaIHS therapy. No serious adverse events were considered related to ibuprofen therapy. Mortality was lower in both NaIHS groups compared with CC groups. CONCLUSIONS Treatment of COVID-19 pneumonitis with inhalational nebulized NaIHS was associated with rapid improvement in hypoxia and vital signs, with no serious adverse events attributed to therapy. Nebulized NaIHS s worthy of further study in randomized, placebo-controlled trials (ClinicalTrials.gov: NCT04382768).
Collapse
Affiliation(s)
- Oscar Salva
- Clínica Independencia, Munro, Buenos Aires, Argentina
| | | | - Celia S Giler
- Clínica Independencia, Munro, Buenos Aires, Argentina
| | | | | | - Sonia E Muñoz
- Instituto de Investigaciones en Ciencias de la Salud, Ciudad Universitaria, Córdoba, Argentina
| | - Mariana N Carrillo
- Instituto de Investigaciones en Ciencias de la Salud, Ciudad Universitaria, Córdoba, Argentina
| | - Daniela J Porta
- Instituto de Investigaciones en Ciencias de la Salud, Ciudad Universitaria, Córdoba, Argentina
| | - Germán Ambasch
- Sanatorio Mayo Privado SA, Ciudad de Córdoba, Córdoba, Argentina
| | - Esteban Coscia
- Sanatorio Mayo Privado SA, Ciudad de Córdoba, Córdoba, Argentina
| | | | - Germán D Bueno
- Sanatorio Mayo Privado SA, Ciudad de Córdoba, Córdoba, Argentina
| | - Jorge O Fandi
- Clínica Independencia, Munro, Buenos Aires, Argentina
| | | | | | | | - Hernán A Pérez
- Sanatorio Alive, Ciudad de Córdoba, Córdoba, Argentina.,Department of Diagnostic Radiology and Nuclear Medicine, Center for Advanced Imaging Research, Maryland University, Baltimore, MD, USA
| | - Mauro A Quiroga
- Instituto Modelo de Cardiología, Ciudad de Córdoba, Córdoba, Argentina
| | | | | | | | | | | | - Galia I Kalayan
- CEPROCOR, Ciudad de Santa María de Punilla, Córdoba, Argentina
| | - Dante M Beltramo
- CEPROCOR, Ciudad de Santa María de Punilla, Córdoba, Argentina.,CONICET, Ciudad de Santa María de Punilla, Córdoba, Argentina
| | - Néstor H García
- Instituto de Investigaciones en Ciencias de la Salud, Ciudad Universitaria, Córdoba, Argentina. .,CEPROCOR, Ciudad de Santa María de Punilla, Córdoba, Argentina.
| |
Collapse
|
8
|
Salva O, Alasino R, Giller C, Borello J, Doresky A, Karayan G, Beltramo D. Nebulization with alkaline hipertonic ibuprofen induces a rapid increase in platelets circulating in COVID-19 patients but not in healthy subjects. Platelets 2021; 33:471-478. [PMID: 34423724 DOI: 10.1080/09537104.2021.1967918] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
We analyze changes in circulating platelets in COVID-19 positive patients who received conventional treatment Dexamethasone and Enoxaparin (Dexa-Enoxa) compared to patients treated with conventional therapy plus nebulization with alkaline hypertonic ibuprofenate (AHI). Results show that after 24 h of nebulization with AHI, circulating platelets shows an increase about 40% at 24 h and reach 65% at 96 h. In patients with platelets content below 200,000 by microliter the increase was 49% and 79% at 24 and 96 h respectively. In patients with platelets above 200,000 by microliter the increase was 24% and 31% at 24 and 96 h, respectively. The increase of platelets via AHI was similar in both, men and women.To evaluate whether this action of AHI was related to platelets from COVID-19 positive patients or also for healthy people, two controls were included: one of them with 10 healthy volunteers and another one with COVID-19 positive patients hospitalized and treated only with Dexa-Enoxa. Results show that, in healthy volunteers, the number of circulating platelets remains unchanged even after 7 days of treatment with AHI. In COVID-19 positive patients treated only with Dexa-Enoxa for 4 days, platelets increased only 16%.
Collapse
Affiliation(s)
- Oscar Salva
- Departamento de Clínica Médica, Clínica Independencia, Ciudad de Munro, Provincia de Buenos Aires, Argentina
| | - Roxana Alasino
- Programa de Biociencias, Centro De Excelencias En Productos Y Procesos (CEPROCOR), Ministerio de Ciencia y Tecnología de la Provincia de Córdoba, Cordoba, Argentina.,Consejo Nacional de Investigaciones Científicas (CONICET), Ministerio de Ciencia Tecnología e Innovación de la República Argentina, Provincia de Buenos Aires, Argentina
| | - Celia Giller
- Departamento de Clínica Médica, Clínica Independencia, Ciudad de Munro, Provincia de Buenos Aires, Argentina
| | - Julieta Borello
- Programa de Biociencias, Centro De Excelencias En Productos Y Procesos (CEPROCOR), Ministerio de Ciencia y Tecnología de la Provincia de Córdoba, Cordoba, Argentina
| | - Alexis Doresky
- Departamento de Investiagación Clinica, Fundación Respirar, Ciudad Autónoma de Buenos Aires, Provincia de Buenos Aires, Argentina
| | - Galia Karayan
- Departamento de Investiagación Clinica, Fundación Respirar, Ciudad Autónoma de Buenos Aires, Provincia de Buenos Aires, Argentina
| | - Dante Beltramo
- Programa de Biociencias, Centro De Excelencias En Productos Y Procesos (CEPROCOR), Ministerio de Ciencia y Tecnología de la Provincia de Córdoba, Cordoba, Argentina.,Consejo Nacional de Investigaciones Científicas (CONICET), Ministerio de Ciencia Tecnología e Innovación de la República Argentina, Provincia de Buenos Aires, Argentina
| |
Collapse
|
9
|
Upadhyay A, Amanullah A, Joshi V, Dhiman R, Prajapati VK, Poluri KM, Mishra A. Ibuprofen-based advanced therapeutics: breaking the inflammatory link in cancer, neurodegeneration, and diseases. Drug Metab Rev 2021; 53:100-121. [PMID: 33820460 DOI: 10.1080/03602532.2021.1903488] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Ibuprofen is a classical nonsteroidal anti-inflammatory drug (NSAID) highly prescribed to reduce acute pain and inflammation under an array of conditions, including rheumatoid arthritis, osteoarthritis, dysmenorrhea, and gout. Ibuprofen acts as a potential inhibitor for cyclooxygenase enzymes (COX-1 and COX-2). In the past few decades, research on this small molecule has led to identifying other possible therapeutic benefits. Anti-tumorigenic and neuroprotective functions of Ibuprofen are majorly recognized in recent literature and need further consideration. Additionally, several other roles of this anti-inflammatory molecule have been discovered and subjected to experimental assessment in various diseases. However, the major challenge faced by Ibuprofen and other drugs of similar classes is their side effects, and tendency to cause gastrointestinal injury, generate cardiovascular risks, modulate hepatic and acute kidney diseases. Future research should also be conducted to deduce new methods and approaches of suppressing the unwanted toxic changes mediated by these drugs and develop new therapeutic avenues so that these small molecules continue to serve the purposes. This article primarily aims to develop a comprehensive and better understanding of Ibuprofen, its pharmacological features, therapeutic benefits, and possible but less understood medicinal properties apart from major challenges in its future application.KEY POINTSIbuprofen, an NSAID, is a classical anti-inflammatory therapeutic agent.Pro-apoptotic roles of NSAIDs have been explored in detail in the past, holding the key in anti-cancer therapies.Excessive and continuous use of NSAIDs may have several side effects and multiple organ damage.Hyperactivated Inflammation initiates multifold detrimental changes in multiple pathological conditions.Targeting inflammatory pathways hold the key to several therapeutic strategies against many diseases, including cancer, microbial infections, multiple sclerosis, and many other brain diseases.
Collapse
Affiliation(s)
- Arun Upadhyay
- Cellular and Molecular Neurobiology Unit, Indian Institute of Technology Jodhpur, Jodhpur, Rajasthan, India
| | - Ayeman Amanullah
- Cellular and Molecular Neurobiology Unit, Indian Institute of Technology Jodhpur, Jodhpur, Rajasthan, India
| | - Vibhuti Joshi
- Cellular and Molecular Neurobiology Unit, Indian Institute of Technology Jodhpur, Jodhpur, Rajasthan, India
| | - Rohan Dhiman
- Laboratory of Mycobacterial Immunology, Department of Life Science, National Institute of Technology, Rourkela, Odisha, India
| | - Vijay Kumar Prajapati
- Department of Biochemistry, School of Life Sciences, Central University of Rajasthan, Ajmer, Rajasthan, India
| | - Krishna Mohan Poluri
- Department of Biotechnology, Indian Institute of Technology Roorkee, Roorkee, Uttarakhand, India
| | - Amit Mishra
- Cellular and Molecular Neurobiology Unit, Indian Institute of Technology Jodhpur, Jodhpur, Rajasthan, India
| |
Collapse
|
10
|
Tatzber F, Resch U, Lindschinger M, Cvirn G, Wonisch W. Improved protection of filtering facepiece through inactivation of pathogens by hypertonic salt solutions - A possible COVID-19 prevention device. Prev Med Rep 2020; 20:101270. [PMID: 33282639 PMCID: PMC7695550 DOI: 10.1016/j.pmedr.2020.101270] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2020] [Revised: 10/07/2020] [Accepted: 11/19/2020] [Indexed: 02/06/2023] Open
Abstract
The filtering facepiece operates through filtration without the ability to kill the viruses. If the filtration might be combined with antiviral agents simultaneously in the masks, this would be much more efficient during the use of these masks and against cross-infection after being discarded. For centuries, sodium chloride (NaCl) contributes to inhibiting pathogens on various occasions. If aerosol with infectious agents reaches the filtering face-piecé surface of the filtering face-piece, coated with hypertonic saline, they become attracted by hygroscopic salt crystals. Proteins and nucleic acids lose their structural integrity and become inactivated concerning their infectious properties. We provide further evidence for cell growth inhibition with hypertonic saline in yeast cells comprising a defending cell wall. Proliferation was inhibited in a concentration-dependent manner, i.e., above 50 g/L, yeast cell proliferation was completely blocked. At a NaCl concentration of 100 g/L, even decomposition of the original inoculated organisms was observed. Therefore, we conclude that hypertonic saline- coated filtering facepiece might strongly reduce the numbers of infectious particles on their surfaces and thus protect mask carriers efficiently from infections.
Collapse
Affiliation(s)
- Franz Tatzber
- Otto Loewi Research Center, Division of Immunology and Pathophysiology, Medical University of Graz, Austria
| | - Ulrike Resch
- Department of Vascular Biology and Thrombosis Research, Medical University of Vienna, Austria
| | - Meinrad Lindschinger
- Institute of Nutritional and Metabolic Diseases, Outpatient Clinic Laßnitzhöhe, Austria
| | - Gerhard Cvirn
- Otto Loewi Research Center, Division of Physiological Chemistry, Medical University of Graz, Austria
| | - Willibald Wonisch
- Otto Loewi Research Center, Division of Physiological Chemistry, Medical University of Graz, Austria
| |
Collapse
|